Reproductive Health During the COVID-19 Pandemic

• Published in: Journal of obstetrics and gynaecology of India Vol. 71; no. Suppl 1; pp. 7 - 11
• Main Author: Krishna, Usha R.
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01-08-2021
• Subjects: Gynecology; Medicine; Medicine & Public Health; Obstetrics/Perinatology/Midwifery; Review; Review Article; Reproductive health; COVID-19; Abortions; COVID vaccine
• ISSN: 0971-9202; 0975-6434
• DOI: 10.1007/s13224-021-01546-2

Globally reproductive health services such as contraception and abortion are impacted and are not accessible to a considerable population. The International Planned Parenthood Federation reported anticipated shortage of contraception as the lockdown measures led to reduction in the manufacturing of contraceptives. A recent analysis by the Guttmacher Institute estimated the potential effects of the pandemic. It was found that a 10% decline of sexual and reproductive health services due to COVID-19, would mean an additional 15.4 million unintended pregnancies, over 3.3 million unsafe abortions and 28,000 maternal deaths. The UN Secretary General has issued a call to continue the delivery of sexual and reproductive health services even without prescription. The focus is now to provide vaccines, and therefore, a number of research organizations and pharmaceutical industries are working on their production. One of the reasons for vaccine refusal is the concern that it may affect female and male reproductive functions. However, it is important to correct this misunderstanding as vaccination does not affect fertility. In most cases, vaccination during pregnancy and lactation can be considered safe and effective.